COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Selecta Biosciences is a clinical-stage biotech in Watertown, MA that develops SVP-based nanoparticle vaccines and tolerogenic immunotherapies to induce antigen-specific immune tolerance and prevent anti-drug immunity (e.g., SEL‑212).
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
